VP Data Science at Enveda Biosciences. ML for drug discovery. Formerly at Recursion & MIT.
Salt Lake City, UT
Joined December 2010
- Tweets140
- Following434
- Followers288
- Likes219
David Healey retweeted
Mass spectrometry detects thousands of molecules in nature, but most remain unidentified. 🌿
Join the Enveda CASMI 2026 - Molecule ID From Mass Spectra Competition, hosted by @enveda and Kaggle, to build machine learning models that predict 2-D chemical structures from LC-MS/MS spectra.
• Prize Pool: $50,000
• Entry Deadline: December 7, 2026
I'm excited to announce CASMI 2026, the blind challenge hosted by @enveda on Kaggle to address one of the grandest challenges in life science: can you tell the structure of a small molecule from its mass spectrum?
kaggle.com/competitions/enve…
David Healey retweeted
Like the protein folding competition that led to AlphaFold, Enveda just launched CASMI 2026, aimed at one of science’s biggest unsolved challenges.
#CASMI26 is Enveda’s 90-day Kaggle competition challenging AI and machine learning researchers across the globe to develop new ways to identify the vast majority of nature’s chemistry that remains a mystery.
Open through December 14, with $50,000 in prizes.
Learn more about the Critical Assessment of Small Molecule Identification (CASMI) competition: businesswire.com/news/home/2….
#Chemistry #Biology #Science
Metabolomics folks: if you're at #ASMS, stop by Enveda's posters to get sneak peeks of our impending data drop and our upcoming public CASMI small molecule identification competition!
Wednesday: WP 439 (Enveda-180 dataset)
hursday: ThP 341 (CASMI 2016)
David Healey retweeted
There is a LOT of stuff to unpack in Todd's thread here. So let's break it down, shall we?
It is true that about 220k people signed the petition. About 30% were invalid. Another ~9K removed their signatures.
That was the tally over about 100 days of signature gathering. The ..
David Healey retweeted
News! @modal_labs is supporting @RAAIS fellowships with $10,000 credits on their platform, alongside the $5,000 GPU credits from @LambdaAPI.
Working on AI-first, open source research outside big institutions?
Apply at airstreet(dot)com/fellowships
News! We’re delighted to announce that applications are open for a new batch of @RAAIS fellowships - provided support to AI-first, open source research outside big institutions.
Apply at airstreet(dot)com/fellowships
Many thanks to our partners @LambdaAPI for their support.
Walking around the cathedral in #rouen around noon today and suddenly the spire was burning.
David Healey retweeted
Thank you to our friends over at @decodingbio for featuring PRISM, our foundation model for life's chemistry, in their latest newsletter.
To check out the excellent Decoding Bio newsletter: decodingbio.substack.com/p/b…
Mass spectrometry people, if you're at #ASMS this year, come see my talk at the Bruker eXceed symposium Multiomics breakout session Sunday at 12 noon, I'll be talking about our new PRISM foundation model.
David Healey retweeted
Working on ML for Drug Discovery I have been frustrated with the size and/or quality of publicly available datasets to train and benchmark models with, so when my co-founder and I started our company we swore we would open-source some data as quickly as possible.
David Healey retweeted
In a new post with @NaefLuca @vant_ai we ask what is needed for ML to succeed in biological problems and argue that it is necessary to move beyond "white-box data"
michael-bronstein.medium.com…
w inputs from @nathanbenaich @dom_beaini @befcorr @georg_e_winter @schwabpa @ggrigoryanv
David Healey retweeted
🪩The @stateofai 2023 is now here.
Our 6th installment is one of the most exciting years I can remember. The #stateofai report covers everything you *need* to know, covering research, industry, safety and politics.
There’s lots in there, so here’s my director’s cut 🧵
David Healey retweeted
We’re grateful to @ClarivateHealth for recognizing us as a leader in using innovative #AI #ML technologies to upend the drug discovery and development paradigm in their annual “Companies to Watch” report! clarivate.com/lp/companies-t…
David Healey retweeted
We are proud to be selected by the @endpts editorial team as one of the most promising and ambitious #biotech startups! We’re grateful for the recognition of what we’ve built so far and where we are headed next: the clinic in 2024! endpts.com/the-endpoints-11-…
MS2Mol preprint is out! De novo structure prediction of molecules from mass spectra!
David Healey retweeted
We're excited to announce our Series B1, which brings the total round to US $119 M. Led by @KinnevikAB with outsized support of existing investors, the funding will continue to fuel platform growth and progress multiple platform-derived molecules to the clinic in 2023-24 🚀 businesswire.com/news/home/2…
If you're trying to figure out what nature's chemistry looks like, you'll want to be able to predict the mass spectra of molecules.
Check out this blog on our work at @envedabio using graph neural networks to get better and more scalable predictions!
@EnvedaBio, we're building advanced #ML models to learn the language of nature’s chemistry. Today on the blog, @mixterhealey & team describe our latest model, GRAFF-MS, and its elegant solution to a common obstacle to applying ML in #metabolomics: bit.ly/3IJ9yvY.
